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Peptic ulcer disease is a relatively rare entity in the pediatric population. Given the trend toward
multimodal pain control for pain crises in Sickle Cell Disease patients, they are at an increased risk of
developing complications secondary to peptic ulcer disease. We discuss a case of a Sickle Cell Disease
patient on multimodal therapy that presented with a perforated peptic ulcer requiring emergent surgery.
While multimodal therapy helps ease the dependency on narcotic pain medication, it does present other
potential problems like potential bleeding or perforation. For those that can be categorized in this select
group of patients, routine surveillance with esophagogastroduodenoscopy should be considered for
those at highest risk to prevent devastating complications.
 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Peptic ulcer disease in children is relatively rare compared to the
adult populationwith an estimated prevalence of 8.1% in Europe and
17.4% in the US. It is more common in the second decade of life and is
frequentlyattributed toH.pylori infectionand theuseofnonsteroidal
anti-inﬂammatory drugs (NSAIDs) [1]. Patients with Sickle Cell
Disease are at increased risk for developing gastroduodenal ulcers
secondary to intrinsic diseasemechanisms in addition tomedication
related side effects. Pain crises result from episodic sickling events
leading tovaso-occlusionwith ischemiaandsubsequent infarctionof
tissues, which further weakens host defenses [2]. These pain crises
are a commoncauseof hospitalization in this patient population, and
adequate pain control can be difﬁcult to achieve. Multimodal
medications are utilized in this group of patients including opioids,
salicylates, and NSAIDs, which places them at a signiﬁcant risk of
developing ulcerations relative to the general population [3]. Our
case report discusses one such patientwith a perforated peptic ulcer
in the setting of Sickle Cell Disease and NSAID use.
1. Case report
A 13-year old African American male with a past medical history
signiﬁcant for sickle cell anemia (hemoglobin SS disease) andann).
Inc. This is an open access article uconstipation presented to the Medical University of South Carolina
with a one week history of abdominal pain. The character of his
pain was consistent with that of prior pain crises until the evening
of presentation when he experienced a sudden onset of worsening
very sharp abdominal pain located in the epigastric region. He was
taken to a nearby hospital where a CT scan of the abdomen
demonstrated a moderate amount of pneumoperitoneum. At that
point the patient was transferred to our hospital for further care. Of
note, the patient reported that he has been taking naproxen
(220 mg tablets) twice daily in combination with his narcotics for
general pain relief. He was also taking stool softeners and Miralax
for management of chronic constipation.
At the time of initial examination at our institution, the patient
appeared critically ill, was febrile (39 C), tachycardic (heart rate of
122), respiratory rate of 24, blood pressure of 120/74, and oxygen
saturation of 95% with supplemental oxygen at 2 L/m. His abdom-
inal exam was remarkable for generalized distention but soft. No
rigidity of the abdominal wall was noted. He had mild to moderate
pain to deep palpation of the abdomen. No clear evidence of acute
peritonitis. Labarotory evaluation was signiﬁcant for WBC 12.7,
hemoglobin 7.2, and platelet count 724. Basic metabolic panel was
unremarkable.
Initial management included ﬂuid resuscitated with intravenous
ﬂuids and packed red blood cells (20 cc/kg). Due to the presence of
pneumoperitoneum, patient was taken to the operating room fornder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 2. Postoperative EGD image demonstrating a healed pre-pyloric ulcer 4 weeks
after the acute event.
C. Johnson-Mann et al. / J Ped Surg Case Reports 14 (2016) 12e14 13diagnostic laparoscopy. Operative ﬁndings were signiﬁcant for
major inﬂammatory changes in the area of the pylorus. The prox-
imal duodenum and antrum of the stomach were adherent to the
undersurface of the liver with omentum around it. There was a
large amount of purulent ﬂuid through the entire abdomen. The
colon was very dilated but no areas of colonic or small bowel
perforation were identiﬁed. Intra-operative Esophagoduodeno-
scopy was performed while the laparoscope was focused on the
duodenum and pyloric region which allowed us to conﬁrm the
presence of a perforation at that site with air extravasation during
insufﬂation. On the intraluminal examination, there was a large
friable ulceration of the gastric mucosa in the pre-pyloric location.
The inﬂammatory phlegmon around the pylorus was so signiﬁcant
that we could not place laparoscopic sutures to close the area of
perforation. For that reason, the procedure was converted to an
exploratory laparotomy via limited upper midline incision. Careful
inspection of the stomach, pylorus, and duodenum revealed the
presence of an inﬂammatory phlegmon 5 cm in diameter at the pre-
pyloric region with a 2 mm pin-hole perforation in the center with
active bile extravasation, consistent with perforated pre-pyloric
ulcer (Fig. 1). A couple of non-absorbable closing sutures were
placed at the perforation site and a Graham patch was performed
with placement of the great omentum over the perforated ulcer
site. The peritoneal cavity was copiously irrigated. A nasogastric
tube was positioned in the stomach just proximal to the perfora-
tion, and a blake drain was placed next to the repair. Cultures were
obtained of the peritoneal ﬂuid.
Postoperatively the patient did not experience any compli-
cations. He underwent an upper GI contrast study on post-
operative day ﬁve that demonstrated mucosal inﬂammatory
changes in the pre-pyloric region, no contrast extravasation, and
no obstruction of the gastric outlet. His NGT was removed at that
point and his diet was advanced as tolerated. The patient was
discharged from the hospital on postoperative day seven.
The patient underwent repeat esophagoduodenoscopy on
postoperative day twenty-ﬁve that demonstrated a well-healed
pre-pyloric ulcer (Fig. 2).Fig. 1. Intraoperative EGD image demonstrating the pre-pyloric ulcer.2. Discussion
Peptic ulcer disease is very rare in the pediatric population.
Pediatric patients that develop this problemare at risk for the type of
complications like perforation and bleeding seen in adult patients.
Comprehensive review of the medical literature demonstrated
multiple series looking at peptic ulcer disease in children, mostly
attributable to H. pylori infections, medications, and stress related
ulcerations [3e7]. There were only 2 reports, one case report and a
case control study that speciﬁcally examined peptic ulcer disease in
sickle cell patients [8,9]. Oftentimes when children do present with
complications like perforation, they are in extremis. A high index of
suspicion is required to promptly treat these children to prevent
deleterious consequences. Fortunately, extensive operations are
usuallynot required in this patient population and laparoscopic and/
or open patch repair has been demonstrated to be safe and effective
[4,7,10]. Patients at high risk for peptic ulcer disease include the
critically ill, steroid users, those unknowingly infectedwithH. pylori,
NSAID users, and sickle cell patients. Our patient tested negative for
H. pylori andhad risk factors of sickle cell anemia in addition toheavy
NSAID use as a multimodal agent during his pain crises. He tested
negative again forH. pyloriduringhis followupendoscopy. Thedelay
in diagnosis of our patient was due to his chronic pain, as his pain
crises often began with abdominal pain. In addition, given the his-
tory of severe constipation the patient received more laxatives and
the primary care providers believed that the constipation was
contributing to his abdominal pain. Interestingly, he did not
demonstrate peritonitis on physical examwhich correlates with the
intraoperative ﬁndings of a fairly well contained perforation, with
minimal bile and enteric contents spillage. The intraoperative
appearanceof his pre-pyloriculcerwasoneof a chroniculcerwithan
acute perforation, and he had not previously been treated with a
proton-pump inhibitor or histamine blocker. It is likely that our
patient had developed a chronic ulcer which subsequently devel-
oped an acute perforation.
Non-narcotic, multimodal agents are an integral part of a well-
designed pain regimen for sickle cell patients to prevent narcotic
dependence. Review of the literature fails to yield novel therapies
for prevention of perforated peptic ulcers other than routine use of
proton pump inhibitor or histamine blocker therapy in people with
known ulcers and preventing ulcer formation with smoking
C. Johnson-Mann et al. / J Ped Surg Case Reports 14 (2016) 12e1414cessation and minimal use of NSAIDs. For this particular patient
population where NSAID therapy is a mainstay of decreasing their
reliance on narcotic pain medication, minimizing adverse effects
with a mandatory proton pump inhibitor regimen as well as
scheduled surveillance endoscopy is the best method to reduce this
risk. Another option is incorporating the use of Carafate which is
routinely used in our adult bariatric population for anastomotic
ulcers when identiﬁed. NSAID therapy needs to be discontinued
once ulcers are identiﬁed and other strategies for appropriate pain
control need to be instituted at the discretion of the primary
physician managing the pain regimen. A low threshold for perfo-
rated peptic ulcer disease should be present in this population to
prevent their acute pain crisis from masking a serious underlying
condition as in our patient in this case report.
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